- Home
- IMNM vs UDMY Comparison
IMNM vs UDMY Comparison
Compare IMNM & UDMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMNM
- UDMY
- Stock Information
- Founded
- IMNM 2006
- UDMY 2009
- Country
- IMNM United States
- UDMY United States
- Employees
- IMNM N/A
- UDMY N/A
- Industry
- IMNM Medicinal Chemicals and Botanical Products
- UDMY Other Consumer Services
- Sector
- IMNM Health Care
- UDMY Real Estate
- Exchange
- IMNM Nasdaq
- UDMY Nasdaq
- Market Cap
- IMNM 945.8M
- UDMY 1.1B
- IPO Year
- IMNM 2020
- UDMY 2021
- Fundamental
- Price
- IMNM $9.69
- UDMY $7.20
- Analyst Decision
- IMNM Strong Buy
- UDMY Buy
- Analyst Count
- IMNM 8
- UDMY 10
- Target Price
- IMNM $24.75
- UDMY $9.89
- AVG Volume (30 Days)
- IMNM 756.6K
- UDMY 1.6M
- Earning Date
- IMNM 08-06-2025
- UDMY 10-28-2025
- Dividend Yield
- IMNM N/A
- UDMY N/A
- EPS Growth
- IMNM N/A
- UDMY N/A
- EPS
- IMNM N/A
- UDMY N/A
- Revenue
- IMNM $12,589,000.00
- UDMY $795,538,000.00
- Revenue This Year
- IMNM N/A
- UDMY $2.51
- Revenue Next Year
- IMNM $154.73
- UDMY $4.18
- P/E Ratio
- IMNM N/A
- UDMY N/A
- Revenue Growth
- IMNM 16.74
- UDMY 3.93
- 52 Week Low
- IMNM $5.15
- UDMY $5.68
- 52 Week High
- IMNM $16.73
- UDMY $10.61
- Technical
- Relative Strength Index (RSI)
- IMNM 48.73
- UDMY 58.21
- Support Level
- IMNM $8.67
- UDMY $6.65
- Resistance Level
- IMNM $9.71
- UDMY $7.41
- Average True Range (ATR)
- IMNM 0.63
- UDMY 0.23
- MACD
- IMNM -0.04
- UDMY 0.06
- Stochastic Oscillator
- IMNM 51.64
- UDMY 87.64
About IMNM Immunome Inc.
Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.
About UDMY Udemy Inc.
Udemy Inc operates a marketplace platform at the center of a vibrant knowledge network. The company operates under two operating and reportable segments Consumer and Enterprise, out of which the Enterprise segment derives the maximum revenue. Geographically, the company derives maximum revenue from North America. The company leverages data, technology, and insights for effective learning experiences. It helps individuals and organizations to possess effective skill acquisition and development with flexibility.